Switch Study of Existing Atypical Antipsychotics to Bifeprunox

Completed · Phase 3

Conditions studied: Schizophrenia and Schizoaffective Disorder

In brief

The study will evaluate the safety and tolerability of switching subjects with schizophrenia or schizoaffective disorder from their existing antipsychotic medication to Bifeprunox.

Key facts

Study ID

NCT00347425

Run by

Solvay Pharmaceuticals

People needed

286

Starts

2006-12-01

Expected to finish

2008-02-01

Last updated by the study team

2008-05-21

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Males or females, 18-65 years, meeting DSM-IV TR diagnosis of Schizophrenia or Schizoaffective Disorder for whom a switch is indicated

You may not qualify if…

• Acutely psychotic or with a current Axis I primary psychiatric diagnosis other than schizophrenia or schizoaffective disorder based on DSM-IV TR criteria

Where it is running

• Site 194 — Little Rock, Arkansas, United States
• Site 178 — Anaheim, California, United States
• Site 167 — Cerritos, California, United States
• Site 189 — Cerritos, California, United States
• Site 183 — Culver City, California, United States
• Site 140 — Garden Grove, California, United States
• Site 162 — La Palma, California, United States
• Site 190 — Long Beach, California, United States
• Site 173 — Oceanside, California, United States
• Site 175 — Paramount, California, United States
• Site 136 — Pasadena, California, United States
• Site 184 — Sacramento, California, United States
• Site 152 — San Diego, California, United States
• Site 186 — San Diego, California, United States
• Site 133 — Santa Ana, California, United States
• Site 171 — Torrance, California, United States
• Site 197 — Boca Raton, Florida, United States
• Site 156 — Gainesville, Florida, United States
• Site 188 — Hialeah, Florida, United States
• Site 193 — Jacksonville, Florida, United States
• Site 154 — Miami, Florida, United States
• Site 163 — North Miami, Florida, United States
• Site 168 — North Miami, Florida, United States
• Site 166 — Orange City, Florida, United States
• Site 148 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.